DUBLIN--(BUSINESS WIRE)--Sep 23, 2022--
The "Global Genomic Biomarker Market Research and Forecast 2020-2027" report has been added to ResearchAndMarkets.com's offering.
The global genomics biomarker market is projected to exhibit a CAGR of over 15% during the forecast period. Genomic biomarkers is a field of science that aims for the collective characterization and quantification of genes. Genomics additionally includes the sequencing and analysis of genomes using high-throughput DNA sequencing and bioinformatics for assembling and analyzing the function and structure of entire genomes.
Major factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, neurological disorders, and others. Other driving factors include increasing research and investment in the field of genomic biomarkers and the use of genomic biomarker services for the enhancement of drug development pipelines.
However, some factors are restraining the market growth that includes reimbursement challenges and limited market capabilities in underdeveloped markets. Genomic biomarkers in the development of personalized medicine and rising demand from emerging economies are the factors to create opportunities for the market across the globe.
The Report Covers
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/9kukxz
View source version on businesswire.com:https://www.businesswire.com/news/home/20220923005319/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/23/2022 08:44 AM/DISC: 09/23/2022 08:44 AM
http://www.businesswire.com/news/home/20220923005319/en